Aligos Therapeutics Inc
(ALGS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -128,332 | -90,618 | -57,492 | -27,674 | -108,543 |
| Depreciation Amortization | 3,864 | 2,828 | 1,859 | 910 | 3,559 |
| Accounts payable and accrued liabilities | 9,429 | 5,149 | 28 | -4,741 | 9,436 |
| Other Working Capital | -4,651 | -198 | -3,386 | -5,788 | 16,063 |
| Other Operating Activity | 4,028 | 4,657 | 6,177 | 7,497 | 5,222 |
| Operating Cash Flow | $-115,662 | $-78,182 | $-52,814 | $-29,796 | $-74,263 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 20,304 | 8,039 | 10,000 | 10,000 | 48,003 |
| PPE Investments | -892 | -556 | -459 | -307 | -2,064 |
| Purchase Of Investment | -16,390 | -982 | N/A | N/A | -13,184 |
| Sale Of Investment | N/A | 13,000 | 10,000 | N/A | N/A |
| Investing Cash Flow | $3,022 | $19,501 | $19,541 | $9,693 | $32,755 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -79 | -59 | -37 | -18 | -58 |
| Common Stock Issued | 79,631 | 78,911 | N/A | 96 | 156,927 |
| Other Financing Activity | -875 | -727 | 210 | 0 | 35,479 |
| Financing Cash Flow | $78,677 | $78,125 | $173 | $78 | $192,348 |
| Beginning Cash Position | 220,943 | 220,943 | 220,943 | 220,943 | 70,103 |
| End Cash Position | 186,980 | 240,387 | 187,843 | 200,918 | 220,943 |
| Net Cash Flow | $-33,963 | $19,444 | $-33,100 | $-20,025 | $150,840 |
| Free Cash Flow | |||||
| Operating Cash Flow | -115,662 | -78,182 | -52,814 | -29,796 | -74,263 |
| Capital Expenditure | -892 | -556 | -459 | -307 | -2,064 |
| Free Cash Flow | -116,554 | -78,738 | -53,273 | -30,103 | -76,327 |